Moreover, hesperetin has been demonstrated to greatly lessen the manifestations of DSS-induced colitis, suppress RIPK3 and MLKL expression, and deactivate their necroptosis signaling pathways [126]. This evidence concerns the gene RIPK3 and colitis.